Comment on the symposium article "Fertility after treatment for Hodgkin's disease", by Z. Blumenfeld, E. Dann, I. Avivi et al. (Ann Oncol 2002; 13 Suppl 1: 138-147).
Bohlmann
M K
MK
von Wolff
M
M
Strowitzki
T
T
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005298:Fertility / Q000187:drug effects*; D005300:Fertility Agents, Female / Q000494:pharmacology*; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D009926:Organ Preservation / Q000379:methods*; D010053:Ovary / Q000502:physiology; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced / Q000517:prevention & control*; D015203:Reproducibility of Results
D018931:Antineoplastic Agents, Hormonal; D005300:Fertility Agents, Female; D007987:Gonadotropin-Releasing Hormone